Bulletin
Investor Alert

Intellia Therapeutics Inc.

NAS: NTLA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Aug 18, 2022, 6:35 p.m.

/zigman2/quotes/207821052/composite

$

59.70

Change

+0.23 +0.39%

Volume

Volume 14,390

Quotes are delayed by 20 min

/zigman2/quotes/207821052/composite

Today's close

$ 59.56

$ 59.47

Change

-0.09 -0.15%

Day low

Day high

$57.62

$59.96

Open

52 week low

52 week high

$37.08

$180.59

Open

Annual Financials for Intellia Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 26.12M30.43M43.1M57.99M33.05M
Cost of Goods Sold (COGS) incl. D&A ----6.89M
COGS excluding D&A -----
Depreciation & Amortization Expense 2.99M4.46M5.59M6.31M6.89M
Depreciation 2.99M4.46M5.59M6.31M6.89M
Amortization of Intangibles -----
Gross Income ----26.16M
20172018201920202021 5-year trend
SG&A Expense 92.68M116.84M143.88M188.27M294.01M
Research & Development 67.65M89.12M108.41M144.1M222.92M
Other SG&A 25.03M27.73M35.47M44.17M-
Other Operating Expense -----
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense -----
Non-Operating Interest Income 2.01M5.53M6.84M2.35M1.28M
Equity in Affiliates (Pretax) ----(1.33M)
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (67.54M)(85.34M)(99.53M)(134.23M)(267.89M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (67.54M)(85.34M)(99.53M)(134.23M)(267.89M)
Minority Interest Expense -----
Net Income (67.54M)(85.34M)(99.53M)(134.23M)(267.89M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (67.54M)(85.34M)(99.53M)(134.23M)(267.89M)
Preferred Dividends -----
Net Income Available to Common (67.54M)(85.34M)(99.53M)(134.23M)(267.89M)
EPS (Basic) (1.88)(1.98)(2.11)(2.40)(3.78)
Basic Shares Outstanding 36.01M43.07M47.25M55.99M70.89M
EPS (Diluted) (1.88)(1.98)(2.11)(2.40)(3.78)
Diluted Shares Outstanding 36.01M43.07M47.25M55.99M70.89M
EBITDA (66.56M)(86.41M)(100.78M)(130.27M)(260.96M)
Link to MarketWatch's Slice.